The quality of life after a total gastrectomy with extended lymphadenectomy and omega type oesophagojejunostomy for gastric adenocarcinoma without distant metastases

69 patients were included. Lithuanian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cancer 30 was sent to all of them from six months to two years after gastric surgery for self-completion. 34 questionnaires were filled and were used as material for further analysis. Influence of age (≥ 65 vs？<？65), sex, clinical stage (I–II vs III), surgical complication, and adjuvant chemotherapy was assessed on QOL in this retrospective cross-sectional case series study.The global health status was better in the group of patients aged over 65 (63.0 points vs 46.4, P？=？0.0509). The functional scales were higher in the same group of patients. Significant difference was only observed on the social scale in favour of elders (P？=？0.0039). Sex, clinical stage, surgical complications, and postoperative chemotherapy had no significant influence on any aspect of QOL.The global QOL and the social functioning was better in patients aged 65？years and over, compared to patients under the age of 65 in the period of 6 to 18？months after a total gastrectomy with D2 lymphadenectomy and Omega esophagojejunostomy.Improving cancer therapy leads to increasing survival rates. In addition to this, there is more attention being placed on the quality of life (QOL) which is mostly dependent on cancer diagnosis and complex treatment [1]. Thorough assessment on the QOL of patients is especially important when surgery is applied as a main option of treatment, as the operated patients often suffer from various functional and psychological symptoms for a considerably longer time than the average amount of months following the surgery. These symptoms and other aspects of health which necessitate for changes of lifestyle, have to be analysed by investigating the QOL.QOL is a multidimensional construct which represents comfort and well-being of the patients, secondary to the disease and treatment [2]. Research has shown that patients want information not o